Sweden· SE-19990507000031
Sandostatin LAR 30 mg Pulver och vätska till injektionsvätska, suspension
A medicinal product containing octreotide, registered in Sweden by Novartis Sverige AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Octreotide
- Manufacturer
- Novartis Sverige AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19990507000031
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Octreotide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumOctreoteva Long Acting 30 mgTeva
- SpainOCTREOTIDA RATIOPHARM 30 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFGRatiopharm Espana S.A.
- United KingdomOlatuton 30mg powder and solvent for prolonged-release suspension for injection vialsTeva UK Ltd
- IcelandOctreoanneTeva B.V.*
- NetherlandsSandostatine LAR 30 mg, poeder en oplosmiddel voor suspensie voor injectieNovartis Pharma B.V.
- PolandOktevaTeva B.V.
- NorwaySandostatin LARNovartis Norge (2)
- SwitzerlandOctreotid-Mepha LA 30 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-InjektionssuspensionMepha Pharma AG
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Octreotide Ratiopharm, Sandostatin
- Belgium · Octreoteva Long Acting, Octreotide Qilu
- Bulgaria · Octreotid Lyomark, Октреотид Lai Тева
- Cyprus · Octreotide Rompharm, Sandostatin
- Czechia · Octreotide Teva, Octreotide Teva B.V.
- Germany · Octreo Ratiopharm, Octreotid Bendalis
- Denmark · Octreoanne, Octreotid Sun
- Estonia · Octreotide Teva, Sandostatin
- Spain · Octreotida Gp-Pharm, Octreotida Sun
- Finland · Octreotide Orion, Octreotide Ratiopharm
- France · Octreotide Arrow, Octreotide Hospira
- United Kingdom (Northern Ireland) · Octreotide Chemi, Octreotide Hospira Uk
- Greece · Okrodin, Sandostatin
- Croatia · Oktreotid Teva, Sandostatin
- Hungary · Oktreotid Teva, Sandostatin
- Ireland · Octreotide Pfizer Healthcare Ireland, Olatuton
- Iceland · Octreoanne, Oczyesa
- Italy · Octreotide Bioindustria L.I.M., Octreotide Sun
- Liechtenstein · Oczyesa
- Lithuania · Octreotide Teva, Sandostatin
- Luxembourg · Octreoteva Long Acting, Sandostatine
- Latvia · Sandostatin, Sandostatin Lar
- Malta · Sandostatin, Sandostatin Lar
- Netherlands · Octreotide Bendalis, Octreotide Depot Teva
- Norway · Octreoanne, Octreotide Orion
- Poland · Okteva, Sandostatin
- Portugal · Octreotido Color, Octreotido Depot Teva
- Romania · Octreotidă Rompharm, Octreotidă Teva
- Slovenia · Oktreotid Teva, Sandostatin
- Slovakia · Sandostatin, Sandostatin Lar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa1271a2-9e3e-4fd5-928a-c50cfad39bdc GET /v1/drugs/fa1271a2-9e3e-4fd5-928a-c50cfad39bdc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19990507000031",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19990507000031",
"product_doc_link": "https://docetp.mpa.se/LMF/Sandostatin%20LAR%20powder%20and%20solvent%20for%20suspension%20for%20injection%20SmPC_09001bee807a6ae6.pdf"
}See everything about octreotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.